Super Religare Labs withdraws IPO on SEBI order; to reapply within 6 weeks

23 May 2011 Evaluate

In order to revise the changes in the shareholding pattern of the diagnostic chain, Super Religare Laboratories (SRL) has withdrawn its initial public offering (IPO) prospectus. The company has been ordered by Securities and Exchange Board of India (SEBI) to make the changes and reapply within 6 weeks.

SRL, founded by billionaire brothers Malvinder and Shivinder Singh, had filed its draft red herring prospectus (DRHP) with SEBI on February 15. In the month of April, Fortis Healthcare, also controlled by the Singh brothers received in-principle approval to acquire a strategic stake in the company. Subsequently, on May 12, Fortis completed the acquisition of 74.59% stake from the SRL promoters for Rs 803 crore. This has made Fortis the new promoter of SRL instead of the Singh brothers.

Also, two private equity (PE) companies -- Avigo Capital Partners and Sabre Partners picked up 9.27% and 4% stake, respectively in the company post the filing of the DRHP. Logos Holding, Prime Trust and Religare Group companies hold the remaining stake. Hence, the capital market regulator has asked the company to incorporate the latest changes in its shareholding pattern and file a new DRHP. 

Peers
Company Name CMP
Apollo Hospital Ent. 7185.05
Max Healthcare Inst 1085.20
Narayana Hrudayalay 1936.60
Aster DM Healthcare 635.00
Global Health 1157.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×